Aminoglikozit ototoksisitesini önleme

1. Arslan E, Orzan E, Santarelli R. Global problem of drug-induced hearing loss. Ann N Y Acad Sci 1999; 884: 1-14.
2. Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg. 2007;15(5):352-7.
3. Schacht J. Biochemical basis of aminoglycoside ototoxicity. Otolaryngol. Clin. 1993; 26: 845-856.
4. Matz G, Rybak L, Roland PS, Hannley M, Friedman R, Manolidis S et al. Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol
S.D.Ü. Tıp pak.
Derg
. 2009:16(2)/ 39-44
42
Aynali, ototoksisite ve önlem
Head Neck Surg. 2004;130(3 Suppl): 79-82.
5. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J. Infect. Dis. 1992;165: 1026-1032.
6. Chen Y, Huang WG, Zha DJ, Qiu JH, Wang JL, Sha SH. Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic. Hear Res. 2007;226(1-2): 178-82.
7. Roland JT, Cohen NL. Vestibuler and auditory ototoxicity. In: Cummings CW, Frederickson JM, Harker LA Krause CJ, Richardson MA, Schüller DE, eds. Otolaryngology Head & Neck Surgery, 2nd ed. St.Louis: Mosby-Year Book,
Inc.1998;3186-97.
8. Priuska EM, Schacht J. Mechanism and prevention of aminoglycoside ototoxicity: outer hair cells as targets and tools. Ear Nose Throat J. 1997;76(3): 164-6, 168, 170-1.
9. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Pharmacogenomics. 2005;6(1): 27-36.
10. Nomura K, Naruse K, Watanabe K, Sokabe M. Aminoglycoside blockade of Ca2(+)-activated K+ channel from rat brain synaptosomal membranes incorporated into planar bilayers. J Membr Biol. 1990;115(3): 241-51.
11. Marcotti W, van Netten SM, Kros CJ. The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels. J Physiol. 2005;567: 505-21.
12. Rybak LP, Ramkumar V. Ototoxicity. Kidney Int. 2007;72(8): 931-5.
13. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005;10(19):
1313-21.
14. Song BB, Schacht J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res. 1996;94(1-2): 87-93.
15.Sha SH, Schacht J. Stimulation of free radical formation by aminoglycoside antibiotics. Hear Res. 1999;128(1-2): 112-8.
16. Popa R, Anniko M, Takumida M. Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol. 2000;120(3): 350-8.
17. Takumida M, Anniko M. Nitric oxide in the inner ear. Curr Opin Neurol. 2002;15(1): 11-5.
18. Nordang L, Anniko M. Nitro-L-arginine methyl
ester: a potential protector against gentamicin ototoxicity. Acta Otolaryngol. 2005;125(10): 1033¬8.
19. Park SK, Choi D, Russell P, John EO, Jung TT. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope. 2004;114(4): 768-71.
20. Kashio A, Sakamoto T, Suzukawa K, Asoh S, Ohta S, Yamasoba T. A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo. J Neurosci Res. 200715;85(7): 1403-12.
21. Lautermann J, McLaren J, Schacht J. Glutathione protection against gentamicin ototoxicity depends onnutritionalstatus. HearRes. 1995;86(1-2): 15¬24.
22. Sha SH, Taylor R, Forge A, Schacht J. Differential vulnerability ofbasal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 2001;155(1-2): 1-8.
23. Feldman L, Efrati S, Eviatar E, Abramsohn R, Yarovoy I, Gersch E, et al. Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated byN-acetylcysteine. KidneyInt. 2007;72(3): 359¬63
24. Tepel M. N-Acetylcysteine in the prevention of ototoxicity. Kidney Int. 2007;72(3): 359-63.
25. Jiang H, Sha SH, Schacht J. NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res. 2005;79(5):
644-51.
26. Fetoni AR, Sergi B, Scarano E, Paludetti G, Ferraresi A, Troiani D. Protective effects of alpha-tocopherol against gentamicin-induced Oto-vestibulo toxicity: an experimental study. Acta Otolaryngol. 2003;123(2): 192-7.
27. Conlon BJ, Aran JM, Erre JP, Smith DW. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear Res. 1999;128(1-2): 40-4.
28. Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Spray D, et al. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol. 1997;18(5): 559-71.
29.Sha SH, Schacht J. vAntioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential
S.D.Ü. Tıp pak.
Derg
. 2009:16(2)/ 39-44
Aynali, ototoksisite ve önlem
43
protectant. Hear Res. 2000;142(1-2): 34-40.
30. Campbell KC, Meech RP, Klemens JJ, Gerberi MT, Dyrstad SS, Larsen DL, et al. Prevention of noise- and drug-induced hearing loss with D-methionine. Hear Res. 2007;226(1-2): 92-103.
31. Horiike O, Shimogori H, Yamashita H. Effect of edaravone on streptomycin-induced vestibulotoxicity in the Guinea pig. Laryngoscope. 2004 Sep;114(9): 1630-2.
32. Asplund MS, Lidian A, Linder B, Takumida M, Anniko M. Protective effect of edaravone against tobramycin-induced ototoxicity. Acta Otolaryngol. 2008;13: 1-6.
33. Pirvola U, Xing-Qun L, Virkkala J, Saarma M, Murakata C, Camoratto AM, et al. Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation. JNeurosci. 2000;20(1): 43-50.
34. Ylikoski J, Xing-Qun L, Virkkala J, Pirvola U. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res. 2002;166(1-2): 33-43.
35. Wang J, Van De Water TR, Bonny C, de Ribaupierre F, Puel JL, Zine A. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci. 2003;23(24): 8596-607.
36. Mostafa BE, Tawfik S, Hefnawi NG, Hassan MA, Ismail FA. The role of deferoxamine in the prevention of gentamicin ototoxicity: a histological and audiological study in guinea pigs. Acta Otolaryngol. 2007;127(3): 234-9.
37. Conlon BJ, Perry BP, Smith DW. Attenuation of neomycin ototoxicity by iron chelation. Laryngoscope. 1998;108(2):284-7.
38. Sinswat P, Wu WJ, Sha SH, Schacht J. Protection from ototoxicity of intraperitoneal gentamicin in guinea pig. Kidney Int. 2000;58(6): 2525-32.
39. Song BB, Sha SH, Schacht J. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity. Free Radic Biol Med. 199815;25(2): 189-95.
40. Crisanti P, Laplace O, Lecain E, Jonet L, Jeanny JC, Omri B. The role of PKCzeta in NMDA-induced retinal ganglion cell death: prevention by aspirin. Apoptosis. 2006;11(6): 983-91.
41. Dehne N, Rauen U, de Groot H, Lautermann J. Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res.
2002;169(1-2): 47-55.
42. Kawamoto K, Yagi M, Stöver T, Kanzaki S, Raphael Y. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther. 2003;7(4): 484-92.
43. Kawamoto K, Sha SH, Minoda R, Izumikawa M, Kuriyama H, Schacht J, et al. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther. 2004;9(2): 173-81.
44. McFadden SL, Ding D, Salvemini D, Salvi RJ. M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity.
Toxicol Appl Pharmacol. 2003;186(1):46-54. 45.Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 2005;11(3): 271-6.
46. Kimura N, Nishizaki K, Orita Y, Masuda Y. 4-methylcatechol, a potent inducer of nerve growth factor synthesis, protects spiral ganglion neurons from aminoglycoside ototoxicity--preliminary report. Acta Otolaryngol Suppl. 1999;540: 12-5.
47. Duan M, Agerman K, Ernfors P, Canlon B. Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc Natl Acad Sci USA. 2000;97(13): 7597¬602.
48. Basile AS, Brichta AM, Harris BD, Morse D, Coling D, Skolnick P. Dizocilpine attenuates streptomycin-induced vestibulotoxicity in rats. NeurosciLett. 1999;265(2): 71-4.
49. Hester TO, Jones RO, Clerici WJ. Protection against aminoglycoside otic drop-induced ototoxicity by a spin trap: I. Acute effects. Otolaryngol HeadNeck Surg. 1998;119(6): 581¬7.
50. Ding D, McFadden SL, Browne RW, Salvi RJ. Late dosing with ethacrynic acid can reduce gentamicin concentration in perilymph and protect cochlear hair cells. Hear Res. 2003;185(1-2): 90¬6.
51. Corbacella E, Lanzoni I, Ding D, Previati M, Salvi R. Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures. Hear Res. 2004;197(1-2): 11-8.
52.Ohtani I, Ohtsuki K, Aikawa T, Sato Y, Anzai T, Ouchi J, Saito T. Protective effect of fosfomycin against aminoglycoside ototoxicity. ORL J
S.D.Ü. Tıp pak.
Derg
. 2009:16(2)/ 39-44
44
Aynali, ototoksisite ve önlem
Otorhinolaryngol Relat Spec. 1985; 47(1): 42-8
53. Battaglia A, Pak K, Brors D, Bodmer D, Frangos JA,
Rya
n AF. Involvement of ras activation in toxic hair cell damage of the mammalian cochlea. Neuroscience. 2003;122(4): 1025-35.
54. Bodmer D, Brors D, Bodmer M, Ryan AF. Rescue of auditory hair cells from ototoxicity by CEP-11 004, an inhibitor of the JNK signaling pathway. Laryngorhinootologie. 2002;81(12): 853-6.
55. Jung HW, Chang SO, Kim CS, Rhee CS, Lim DH. Effects of Ginkgo biloba extract on the cochlear damage induced by local gentamicin installation in guinea pigs. J Korean Med Sci. 1998;13(5): 525¬8.
56. Long M, Smouha EE, Qiu D, Li F, Johnson F, Luft B. Flavanoid ofDrynaria fortunei protects against gentamicin ototoxicity. Phytother Res. 2004;18(8): 609-14.